Myotrophin IGF-1: CEPH will present data from its European Phase III trial on Oct. 31 at the International Symposium on ALS/MND in Dublin. Data from its initial

Cephalon Inc. (CEPH), West Chester, Penn. Product: Myotrophin IGF-1 Indication: Amyotrophic lateral sclerosis Status: CEPH will present data from its European Phase III trial on Oct. 31 at the Intern...